Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the completion of Phase 1 clinical ...

Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for ...

Research uncovers how P-stalk ribosomes regulate cytokine responses, driving immune evasion in tumors across multiple cancer ...

Long term exposure to arsenic in water may increase cardiovascular disease and especially heart disease risk even at exposure levels below the federal regulatory limit (10µg/L) according to a new ...

Maternal stress and depression during pregnancy and postpartum are linked to DNA methylation changes in infants, potentially ...

Climate change has contributed to a sharp rise in fire-related deaths globally, with mortality rates more than doubling from ...

Researchers used multimodal wearable sensors and machine learning to track real-time fatigue in manufacturing workers, ...

A Ukrainian researcher has developed a new digital tool for detecting autism and developmental delay in children. Her research has been published in Cambridge University Press journal Cambridge Prisms ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy ...

The scourge of scurvy, which is caused by vitamin C deficiency, may be re-emerging amid the cost of living crisis and the rise in weight loss (bariatric) surgery, suggest doctors in the journal BMJ ...

The lifetime risk of an unexpected and sudden death from a cardiovascular cause in the absence of pre-existing heart disease- ...